CEO, 10% Owner of Hemispherx Biopharma Inc (HEB, Financial) William A Carter buys 500,000 shares of HEB on 06/11/2010 at an average price of $0.66 a share.
Hemispherx Biopharma Inc has a market cap of $62.2 million; its shares were traded at around $0.4685 with and P/S ratio of 560.6.
Hemispherx Biopharma Inc has a market cap of $62.2 million; its shares were traded at around $0.4685 with and P/S ratio of 560.6.
CFO Recent Trades:
- Sell: CFO Charles Thomas Bernhardt Iii sold 87,794 shares of HEB stock on 06/15/2010 at the average price of 0.59. Charles Thomas Bernhardt Iii owns at least 177,420 shares after this. The price of the stock has decreased by 20.59% since.
Directors and Officers Recent Trades:
- Buy: Medical Director David R Strayer bought 230,586 shares of HEB stock on 06/16/2010 at the average price of 0.57. David R Strayer owns at least 281,832 shares after this. The price of the stock has decreased by 17.81% since.
- Sell: Medical Director David R Strayer sold 50,900 shares of HEB stock on 06/23/2010 at the average price of 0.55. David R Strayer owns at least 230,932 shares after this. The price of the stock has decreased by 14.82% since.
- Sell: Vice President of Operations Wayne S. Springate sold 83,104 shares of HEB stock on 06/15/2010 at the average price of 0.59. Wayne S. Springate owns at least 103,521 shares after this. The price of the stock has decreased by 20.59% since.
